NMPA Approval

Enfortumab vedotin for Injection

Approval Number

国药准字SJ20240035

Registration Date

August 13, 2024

Drug Information

Generic Name

注射用维恩妥尤单抗

Trade Name

备思复

Dosage Form

注射剂

Strength

30mg/瓶

Drug Type

生物制品

Registration Date

August 13, 2024

Expiry Date

August 12, 2029

Company Address

Sylviusweg 62, 2333 BE Leiden, The Netherlands

Company Address

Kantstraße 2, 33790, Halle/Westfalen, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

注射用维恩妥尤单抗 - NMPA 批准文号 | MedPath